Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication date: 2023

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors:  Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.

Journal: Journal of neurology

Publication date: 2024

Journal: Journal of neurology

Publication Year: 2024

Authors & Co-authors:  Li Ying Y Saul Alice A Taylor Bruce B Ponsonby Anne-Louise AL Simpson-Yap Steve S Blizzard Leigh L Broadley Simon S Lechner-Scott Jeannette J Karabudak Rana R